7,183 Shares in Danaher Corporation $DHR Purchased by Stokes Capital Advisors LLC

Stokes Capital Advisors LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 7,183 shares of the conglomerate’s stock, valued at approximately $1,591,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Main Street Group LTD acquired a new stake in Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher during the 2nd quarter worth $25,000. Clal Insurance Enterprises Holdings Ltd raised its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares in the last quarter. Evolution Wealth Management Inc. lifted its position in shares of Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 104 shares during the period. Finally, Field & Main Bank bought a new stake in shares of Danaher during the 2nd quarter valued at $29,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Barclays increased their price objective on shares of Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Finally, Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $235.23.

Danaher Price Performance

Shares of DHR stock opened at $220.15 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $154.76 billion, a P/E ratio of 39.10, a P/E/G ratio of 2.71 and a beta of 0.76. The business has a fifty day simple moving average of $211.38 and a 200 day simple moving average of $194.62.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.77 earnings per share. On average, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is 28.42%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.